Cargando…
Chlorhexidine and SARS-CoV-2 main protease: Molecular docking study
As the beginning of the COVID-19 pandemic, numerous attempts have been made to identify specific antiviral mouth rinses which may help reduce the salivary viral load of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2). Although the results from in vivo well-controlled clinical studies are...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626784/ https://www.ncbi.nlm.nih.gov/pubmed/36339382 http://dx.doi.org/10.4103/jisp.jisp_39_22 |
_version_ | 1784822809155862528 |
---|---|
author | Grover, Vishakha Kumar, Varinder Puri, Veena Jain, Ashish |
author_facet | Grover, Vishakha Kumar, Varinder Puri, Veena Jain, Ashish |
author_sort | Grover, Vishakha |
collection | PubMed |
description | As the beginning of the COVID-19 pandemic, numerous attempts have been made to identify specific antiviral mouth rinses which may help reduce the salivary viral load of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2). Although the results from in vivo well-controlled clinical studies are yet pending, many contemporary antimicrobial mouth rinses have been explored for potential antiviral properties with respect to SARS-CoV-2. The most widely used compounds such as povidone-iodine, chlorhexidine, hydrogen peroxide, and essential oils have been known to have antiviral activity by targeting the outer lipid membrane or by denaturing the capsid proteins of enveloped virus SARS-CoV. Until now, there has been scanty scientific evidence on the molecular basis of interaction of the gold standard antimicrobial mouth rinse as an underlying mechanism of its anti-SARS-CoV-2 effect. The current communication reports the findings of our in silico docking study pertaining to understand the interactions of chlorhexidine with the most well-studied target of the SARS-CoV main protease. |
format | Online Article Text |
id | pubmed-9626784 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-96267842022-11-03 Chlorhexidine and SARS-CoV-2 main protease: Molecular docking study Grover, Vishakha Kumar, Varinder Puri, Veena Jain, Ashish J Indian Soc Periodontol Short Communication As the beginning of the COVID-19 pandemic, numerous attempts have been made to identify specific antiviral mouth rinses which may help reduce the salivary viral load of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2). Although the results from in vivo well-controlled clinical studies are yet pending, many contemporary antimicrobial mouth rinses have been explored for potential antiviral properties with respect to SARS-CoV-2. The most widely used compounds such as povidone-iodine, chlorhexidine, hydrogen peroxide, and essential oils have been known to have antiviral activity by targeting the outer lipid membrane or by denaturing the capsid proteins of enveloped virus SARS-CoV. Until now, there has been scanty scientific evidence on the molecular basis of interaction of the gold standard antimicrobial mouth rinse as an underlying mechanism of its anti-SARS-CoV-2 effect. The current communication reports the findings of our in silico docking study pertaining to understand the interactions of chlorhexidine with the most well-studied target of the SARS-CoV main protease. Wolters Kluwer - Medknow 2022 2022-09-01 /pmc/articles/PMC9626784/ /pubmed/36339382 http://dx.doi.org/10.4103/jisp.jisp_39_22 Text en Copyright: © 2022 Indian Society of Periodontology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Short Communication Grover, Vishakha Kumar, Varinder Puri, Veena Jain, Ashish Chlorhexidine and SARS-CoV-2 main protease: Molecular docking study |
title | Chlorhexidine and SARS-CoV-2 main protease: Molecular docking study |
title_full | Chlorhexidine and SARS-CoV-2 main protease: Molecular docking study |
title_fullStr | Chlorhexidine and SARS-CoV-2 main protease: Molecular docking study |
title_full_unstemmed | Chlorhexidine and SARS-CoV-2 main protease: Molecular docking study |
title_short | Chlorhexidine and SARS-CoV-2 main protease: Molecular docking study |
title_sort | chlorhexidine and sars-cov-2 main protease: molecular docking study |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626784/ https://www.ncbi.nlm.nih.gov/pubmed/36339382 http://dx.doi.org/10.4103/jisp.jisp_39_22 |
work_keys_str_mv | AT grovervishakha chlorhexidineandsarscov2mainproteasemoleculardockingstudy AT kumarvarinder chlorhexidineandsarscov2mainproteasemoleculardockingstudy AT puriveena chlorhexidineandsarscov2mainproteasemoleculardockingstudy AT jainashish chlorhexidineandsarscov2mainproteasemoleculardockingstudy |